Biotech Stocks Facing FDA Decision In February 2025
February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...
Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
"We are delighted to welcome these distinguished scientists and clinicians to our Scientific Advisory Board," said Dr. Neal Walker, Interim CEO and Chair of the Board of Directors of Aclaris ...
BusinessMirror4d
No studies, clinical trials support use of IV glutathione as a skin-lightening agent, says PDS president
LAST weekend, a Filipina recounted her experience in a video after a beauty procedure where she underwent an intravenous (IV) glutathione procedure. That video has already gone viral and shows the ...
News Medical5d
GLP-1RA initiation linked to new thyroid cancer diagnoses
Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...
News Medical6d
Triple therapy shows strong response in BRAF V600E mutant metastatic colorectal cancer
Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefitted from first-line treatment with the targeted therapies encorafenib and cetuximab plus a mFOLFOX6 chemotherapy ...